Suppr超能文献

BMI1,一种CK2α的新靶点。

BMI1, a new target of CK2α.

作者信息

Banerjee Mustafi Soumyajit, Chakraborty Prabir Kumar, Dwivedi Shailendra Kumar Dhar, Ding Kai, Moxley Katherine M, Mukherjee Priyabrata, Bhattacharya Resham

机构信息

Peggy and Charles Stephenson Cancer Center (OUHSC), University of Oklahoma Health Science Center, 975 NE 10th Street, BRC-1409B, Oklahoma City, OK, 73104, USA.

Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK, USA.

出版信息

Mol Cancer. 2017 Mar 7;16(1):56. doi: 10.1186/s12943-017-0617-8.

Abstract

BACKGROUND

The polycomb group protein, BMI1 plays important roles in chromatin modification, stem cell function, DNA damage repair and mitochondrial bioenergetics. Such diverse cellular functions of BMI1 could be, in part, due to post-translational modifications, especially phosphorylation. To date, AKT has been reported as a kinase that by site specific phosphorylation of BMI1 modulates its oncogenic functions.

METHODS

Immunoprecipitation in conjunction with kinase assay and mass spectrometry was used to determine association with and site specific phosphorylation of BMI1 by CK2α. Functional implications of the BMI1/CK2α axis was examined in cancer cells utilizing siRNA and exogenous gene expression followed by biochemical and phenotypic studies. Correlations between expression of CK2α and BMI1 were determined from cell lines and formalin fixed paraffin embedded tissues representing the normal fallopian tube epithelium and high grade serous ovarian cancer samples.

RESULTS

Here we report that CK2α, a nuclear serine threonine kinase, phosphorylates BMI1 at Serine 110 as determined by in-vitro/ex-vivo kinase assay and mass spectrometry. In ovarian cancer cell lines, expression of CK2α correlated with the phospho-species, as well as basal BMI1 levels. Preventing phosphorylation of BMI1 at Serine 110 significantly decreased half-life and stability of the protein. Additionally, re-expression of the phosphorylatable but not non-phosphorylatable BMI1 rescued clonal growth in endogenous BMI1 silenced cancer cells leading us to speculate that CK2α-mediated phosphorylation stabilizes BMI1 and promotes its oncogenic function. Clinically, compared to normal fallopian tube epithelial tissues, the expression of both BMI1 and CK2α were significantly higher in tumor tissues obtained from high-grade serous ovarian cancer patients. Among tumor samples, the expression of BMI1 and CK2α positively correlated (Spearman coefficient = 0.62, P = 0.0021) with each other.

CONCLUSION

Taken together, our findings establish an important regulatory role of CK2α on BMI1 phosphorylation and stability and implicate the CK2α/BMI1 axis in ovarian cancer.

摘要

背景

多梳蛋白家族成员BMI1在染色质修饰、干细胞功能、DNA损伤修复及线粒体生物能量学中发挥重要作用。BMI1如此多样的细胞功能部分可能归因于翻译后修饰,尤其是磷酸化。迄今为止,AKT已被报道为一种通过对BMI1进行位点特异性磷酸化来调节其致癌功能的激酶。

方法

采用免疫沉淀结合激酶分析和质谱法来确定CK2α与BMI1的结合及BMI1的位点特异性磷酸化。利用小干扰RNA和外源基因表达,随后进行生化和表型研究,在癌细胞中检测BMI1/CK2α轴的功能意义。从代表正常输卵管上皮和高级别浆液性卵巢癌样本的细胞系及福尔马林固定石蜡包埋组织中确定CK2α和BMI1表达之间的相关性。

结果

我们在此报告,通过体外/体内激酶分析和质谱法确定,核丝氨酸苏氨酸激酶CK2α使BMI1的丝氨酸110位点发生磷酸化。在卵巢癌细胞系中,CK2α的表达与磷酸化形式以及基础BMI1水平相关。阻止BMI1丝氨酸110位点的磷酸化显著降低了该蛋白的半衰期和稳定性。此外,可磷酸化但不可磷酸化的BMI1的重新表达挽救了内源性BMI1沉默的癌细胞中的克隆生长,这使我们推测CK2α介导的磷酸化稳定了BMI1并促进其致癌功能。临床上,与正常输卵管上皮组织相比,高级别浆液性卵巢癌患者肿瘤组织中BMI1和CK2α的表达均显著更高。在肿瘤样本中,BMI1和CK2α的表达彼此呈正相关(斯皮尔曼系数 = 0.62,P = 0.0021)。

结论

综上所述,我们的研究结果确立了CK2α对BMI1磷酸化和稳定性的重要调节作用,并表明CK2α/BMI1轴与卵巢癌有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3972/5341428/9a8fb4792866/12943_2017_617_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验